Earnings History Data for Longeveron Inc. (LGVN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Longeveron Inc.

Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-02-2024	AH		LGVN	Longeveron Inc.	13.02	-0.25	-0.21	-0.21	Longeveron GAAP EPS of -$1.02 misses by $0.07, revenue of $0.71M in-line [2/27/2024 5:28 PM]	0.5444	-0.03 (-5.94%)	0.55	-0.03 (-4.96%)	0.42 - 4.40	245,766	170,000	17,048
Longeveron GAAP EPS of -$1.02 misses by $0.07, revenue of $0.71M in-line [2/27/2024 5:28 PM]
10-11-2023	PM		LGVN	Longeveron Inc.	41.70	-0.28	-0.24	-0.25	Longeveron GAAP EPS of -$0.28 misses by $0.04, revenue of $0.2M misses by $0.07M [11/10/2023 7:33 AM]	1.79	-0.14 (-7.25%)	1.90	-0.03 (-1.55%)	1.50 - 4.58	49,618	90,000	6,269
Longeveron GAAP EPS of -$0.28 misses by $0.04, revenue of $0.2M misses by $0.07M [11/10/2023 7:33 AM]
11-08-2023	PM		LGVN	Longeveron Inc.	68.30	-0.27	-0.26	-0.27	Longeveron reports Q2 results [8/11/2023 10:57 AM]	3.27	0.02 (0.48%)	3.14	-0.11 (-3.38%)	2.50 - 6.72	12,820	20,000	2,049
Longeveron reports Q2 results [8/11/2023 10:57 AM]
12-05-2023	PM	8:00 AM ET (May 12)	LGVN	Longeveron	84.00	-0.22	-0.19	0.00	Longeveron GAAP EPS of -$0.22, revenue of $0.28M [5/12/2023 8:21 AM]	3.30	-0.15 (-4.35%)	3.42	-0.03 (-0.87%)	2.50 - 9.34	162,678	830,000	4,175
Longeveron GAAP EPS of -$0.22, revenue of $0.28M [5/12/2023 8:21 AM] Longeveron GAAP EPS of -$0.22 misses by $0.01, revenue of $0.27M beats by $0.12M [5/12/2023 9:52 AM]
10-03-2023	PM	8:00 AM ET (Mar 10)	LGVN	Longeveron Inc.	72.51	-0.21	-0.10	-0.20	Longeveron GAAP EPS of -$0.21 misses by $0.01 [3/10/2023 8:03 AM]	3.08	-0.40 (-11.64%)	3.48	0.0 (0.00%)	2.80 - 16.77	79,884	20,000	2,825
Longeveron GAAP EPS of -$0.21 misses by $0.01 [3/10/2023 8:03 AM]
14-11-2022	PM	8:00 AM ET (Nov 14)	LGVN	Longeveron Inc.	79.75	-0.25	-0.20	-0.25	Longeveron GAAP EPS of -$0.25 misses by $0.03, revenue of $0.3M beats by $0.2M [11/14/2022 8:03 AM]	3.92	0.01 (0.26%)	3.95	0.04 (1.02%)	2.84 - 45.00	252,028	70,000	6,838
Longeveron GAAP EPS of -$0.25 misses by $0.03, revenue of $0.3M beats by $0.2M [11/14/2022 8:03 AM]
12-08-2022	PM	8:00 AM ET (Aug 12)	LGVN	Longeveron Inc.	128.98	-0.27	-0.23	-0.26	Longeveron GAAP EPS of -$0.27, revenue of $0.5M [8/12/2022 8:01 AM]	5.98	0.04 (0.72%)	6.00	0.06 (1.01%)	2.84 - 45.00	201,355	240,000	12,406
Longeveron GAAP EPS of -$0.27, revenue of $0.5M [8/12/2022 8:01 AM]
13-05-2022	PM	8:00 AM ET (May 13)	LGVN	Longeveron Inc.	163.95	-0.17	-0.21	-0.18	Longeveron GAAP EPS of -$0.17 beats by $0.06, revenue of $0.37M beats by $0.12M [5/13/2022 8:05 AM]	7.93	0.71 (9.83%)	8.00	0.78 (10.80%)	2.84 - 45.00	637,913	400,000	29,713
Longeveron GAAP EPS of -$0.17 beats by $0.06, revenue of $0.37M beats by $0.12M [5/13/2022 8:05 AM] Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results [May-13-22 08:00AM] LGVN: CEO Leaving but Progress Continues [May-13-22 07:12AM]
11-03-2022	PM	8:00 AM ET (Mar 11)	LGVN	Longeveron Inc.	105.51	-0.20	-0.25	0.00	Longeveron GAAP EPS of -$0.20 beats by $0.05, revenue of $0.21M [3/11/2022 8:02 AM]	6.66	-0.28 (-4.03%)	6.09	-0.85 (-12.25%)	2.84 - 45.00	1,564,806	1,020,000	141,833
Longeveron GAAP EPS of -$0.20 beats by $0.05, revenue of $0.21M [3/11/2022 8:02 AM] Longeveron slips after Q4 earnings amid likely delay in key data readout [3/11/2022 8:36 AM] Longeveron Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress [Mar-11-22 08:00AM] LGVN: Longeveron Continues to Make Progress [Mar-11-22 06:10AM]
12-11-2021	PM	Before the open (Nov 12)	LGVN	Longeveron Inc.	67.28	-0.25	0.00	0.00	Longeveron reports Q3 results [11/12/2021 8:03 AM]	3.41	-0.05 (-1.44%)	3.41	-0.05 (-1.45%)	3.20 - 12.48	51,568	130,000	6,470
Longeveron reports Q3 results [11/12/2021 8:03 AM] SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming Deadline LGVN [Nov-11-21 06:50PM] Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2021 Financial Results [Nov-12-21 08:00AM] DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Nov-12-21 07:55AM] LGVN Deadline Alert: Rosen, A Leading Law Firm, Encourages Longeveron Inc. Investors to Secure Counsel Before Important Deadline Today in Securities Class Action - LGVN [Nov-12-21 10:49AM] Last Few Hours to Actively Participate in Longeveron Inc. (LGVN) Class Action - Bronstein, Gewirtz & Grossman, LLC [Nov-12-21 11:00AM] FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Nov-12-21 02:22PM]
13-08-2021	PM	Before the open (Aug 13)	LGVN	Longeveron Inc.	110.10	-0.26	0.00	0.00	Longeveron reports Q2 results [8/13/2021 7:23 AM]	3.88	-1.53 (-28.28%)	5.32	-0.09 (-1.66%)	3.60 - 12.48	1,583,996	40,000	1,124,648
Longeveron reports Q2 results [8/13/2021 7:23 AM] Longeveron meets primary efficacy endpoint in mid-stage trial for aging frailty [8/13/2021 7:37 AM] Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2021 Financial Results [Aug-13-21 07:00AM] Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging Frailty [Aug-13-21 07:00AM]
14-05-2021	PM	Before the open (May 14)	LGVN	Longeveron Inc.	100.47	-0.18	0.00	0.00	Longeveron reports Q1 results [5/14/2021 8:03 AM]	5.30	0.10 (1.92%)	5.08	-0.12 (-2.31%)	5.15 - 12.48	58,284	60,000	300
Longeveron reports Q1 results [5/14/2021 8:03 AM] Longeveron Inc - Ordinary Shares - Class A to Host Earnings Call [May-14-21 06:45AM] Longeveron Inc. Provides Corporate Update and Reports First Quarter 2021 Financial Results [May-14-21 08:00AM]